Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

Share Price is delayed by 15 minutes
Get Live Data
520.00    8.00 (1.56%)
Bid:
520.00
Ask:
521.50
Spread: 1.50 (0.288%)
Market Cap: £1.41b
CHG Live PriceLast checked at - London Stock Exchange

Intraday Chemring Share Chart

CONTRACT AWARD

29 Jan 2013 07:00

RNS Number : 5451W
Chemring Group PLC
29 January 2013
 



FOR IMMEDIATE RELEASE 29 JANUARY 2013

 

CHEMRING GROUP PLC

CHEMRING DETECTION SYSTEMS AWARDED $28.5 MILLION CONTRACT

 

 

Chemring Group PLC ("Chemring") is pleased to announce that its US subsidiary, Chemring Detection Systems, has been awarded a $28.5 million delivery order against a multi-year IDIQ contract to supply chemical detection systems to the US Army. The Edgewood Contracting Division of the US Army Contracting Command-APG has ordered more than 100 Joint Services Lightweight Standoff Chemical Agent Detectors ("JSLSCAD"). The JSLSCAD remotely detects and identifies multiple chemical agent vapour clouds at ranges up to 5km. These systems will be installed in the Stryker Nuclear Biological Chemical Reconnaissance Vehicle.

 

Mark Papworth, Chief Executive of Chemring, said, "Chemring continues to provide reliable JSLSCADs to the US Army, and we are proud to support the production of this critical equipment. This award is especially important in light of the current international chemical threats. The JSLSCAD offers a unique capability that provides excellent long range, chemical agent detection for the Armed Forces."

 

-ENDS-

 

Chemring Group PLC

Rupert Pittman - Group Director of Communications and Investor Relations

01489 881 880 / rupertp@chemring.co.uk

 

MHP Communications

Andrew Jaques / James White

0203 128 8100

 

 

Notes to Editors:

 

Chemring is a market leading manufacturing business supplying high technology electronics and energetic products to over sixty countries around the world. Chemring has a diverse portfolio of products that predominantly protect military people and platforms, providing insurance against a constantly changing threat. These range from countermeasures to protect aircraft, to ground penetrating radar to protect troops and vehicles from improvised explosive devices. Chemring Detection Systems is a world leader in solutions to detect and identify chemical, biological and explosive threats.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTNKFDDDBKBODB
Date   Source Headline
29th Aug 20237:00 amRNSTransaction in Own Shares
25th Aug 20237:00 amRNSTransaction in Own Shares
24th Aug 20237:00 amRNSTransaction in Own Shares
23rd Aug 20237:00 amRNSTransaction in Own Shares
22nd Aug 20237:00 amRNSTransaction in Own Shares
21st Aug 20237:00 amRNSTransaction in Own Shares
18th Aug 20237:00 amRNSTransaction in Own Shares
17th Aug 20237:00 amRNSTransaction in Own Shares
16th Aug 20237:00 amRNSTransaction in Own Shares
15th Aug 20237:00 amRNSTransaction in Own Shares
14th Aug 20237:00 amRNSTransaction in Own Shares
11th Aug 20237:00 amRNSTransaction in Own Shares
10th Aug 20237:00 amRNSTransaction in Own Shares
8th Aug 20237:00 amRNSUpdate on appointment of Chief Financial Officer
8th Aug 20237:00 amRNSTransaction in Own Shares
7th Aug 20237:00 amRNSTransaction in Own Shares
4th Aug 20234:16 pmRNSDirector/PDMR Shareholding
4th Aug 20234:15 pmRNSDirector/PDMR Shareholding
4th Aug 20237:00 amRNSTransaction in Own Shares
3rd Aug 20237:00 amRNSTransaction in Own Shares
2nd Aug 20237:00 amRNSTransaction in Own Shares
1st Aug 20239:26 amRNSTotal Voting Rights
1st Aug 20237:00 amRNSShare buyback programme
3rd Jul 20237:00 amRNSDirector/PDMR Shareholding
21st Jun 20239:47 amRNSBlock listing Interim Review
13th Jun 20237:00 amRNSAppointment of non-executive director
6th Jun 20237:00 amRNSHalf year results to 30 April 2023
1st Jun 202310:28 amRNSTotal Voting Rights
24th May 20237:00 amRNSAppointment of Chief Financial Officer
2nd May 20232:51 pmRNSTotal Voting Rights
20th Apr 202312:02 pmRNSDirector Declaration
3rd Apr 20239:25 amRNSTotal Voting Rights
29th Mar 20237:00 amRNSContract Award
28th Mar 20233:29 pmRNSHolding(s) in Company
16th Mar 20234:23 pmRNSDoc re. Ordinary & Special Resolutions
15th Mar 20233:11 pmRNSResult of AGM
15th Mar 20237:00 amRNSAGM Trading Update
1st Mar 202310:33 amRNSTotal Voting Rights
24th Feb 20239:07 amRNSDirector Declaration
1st Feb 202310:10 amRNSTotal Voting Rights
24th Jan 20233:09 pmRNSDirector/PDMR Shareholding
23rd Jan 20237:00 amRNSDirectorate Change
16th Jan 202310:44 amRNSNotice of AGM
9th Jan 20237:10 amRNSDirector Declaration
3rd Jan 202310:54 amRNSTotal Voting Rights
20th Dec 20227:00 amRNSDirector/PDMR Shareholding
20th Dec 20227:00 amRNSDirector/PDMR Shareholding
20th Dec 20227:00 amRNSDirector/PDMR Shareholding
19th Dec 20223:41 pmRNSBlock listing Interim Review
14th Dec 202212:31 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.